Insights

Marwood’s Scott Silberberg MA and Mark Slomiany PhD MBA MPA address state regulatory and commercial payor tailwinds in the fertility space; the first of a two-part series

Marwood’s Mark Slomiany, Deborah Freier and Scott Silberberg delineate opportunities in the cosmetic surgery & medspa market, providing perspective on market and regulatory diligence crucial in evaluating individual targets and platforms in the sector.

Mark Slomiany presents a decision analysis structure for evaluating pass through considerations among novel radiopharmaceutical tracers for PET and SPECT.

Marwood presents its proprietary analytics tool for reimbursement claims analysis through a case study of the outpatient orthopedics space in North Carolina. Deb Frier, Kate Gibson, and Mark Slomiany explores payor mix, rate trends, and geographic variability in reimbursement at the intra-state level.

Advances in genetics and a better understanding of the immune system have cracked open the door on the potential of animal-to-human transplants. Marwood’s Stephen Williams, Ph.D. and E. Daley Smith explore xenotransplant technology, early clinical testing, and the regulatory outlook for the procedure.

Marwood’s Mark Slomiany explores the opportunities and trends which labor cost-sensitivity may facilitate in healthcare.

Growth in the substance use disorder (SUD) treatment space has brought significant investor interest. Herein, Mark Slomiany and Deb Frier address future tailwinds and challenges to the industry.